Iterum Therapeutics PLC

NASDAQ ITRM

Download Data

Iterum Therapeutics PLC Gross Working Capital 1 year YoY Change (%) for the quarter ending March 31, 2024: -124.54%

Iterum Therapeutics PLC Gross Working Capital 1 year YoY Change (%) is -124.54% for the quarter ending March 31, 2024, a -273.85% change year over year. Gross working capital is a financial metric that represents the amount of a company's current assets available to cover its current liabilities and short-term debt obligations. It is calculated by subtracting the sum of current liabilities and short-term debt from the total current assets of a company. Gross working capital provides insights into a company's short-term liquidity and its ability to meet its financial obligations in the near future. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Iterum Therapeutics PLC Gross Working Capital for the quarter ending March 31, 2023 was USD 46.11 M.
  • Iterum Therapeutics PLC Gross Working Capital for the quarter ending March 31, 2021 was USD 53.80 M, a 320.61% change year over year.
  • Iterum Therapeutics PLC Gross Working Capital for the quarter ending March 31, 2020 was USD -24.39 M, a -142.68% change year over year.
NASDAQ: ITRM

Iterum Therapeutics PLC

CEO Mr. Corey N. Fishman
IPO Date May 25, 2018
Location Ireland
Headquarters Fitzwilliam Court, Dublin, Ireland, 2
Employees 14
Sector Healthcare
Industry Biotechnology
Description

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Similar companies

HOTH

Hoth Therapeutics Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email